Ahn H Y, Kim M, Ahn Y-T, Sim J-H, Choi I-D, Lee S-H, Lee J H
Interdisciplinary Course of Science for Aging, Yonsei University, Seoul, South Korea.
Research Center for Silver Science, Institute of Symbiotic Life-TECH, Yonsei University, Seoul, South Korea.
Nutr Metab Cardiovasc Dis. 2015 Aug;25(8):724-33. doi: 10.1016/j.numecd.2015.05.002. Epub 2015 May 14.
This study evaluated the triglyceride (TG)-lowering effects of consuming dual probiotic strains of Lactobacillus curvatus (L. curvatus) HY7601 and Lactobacillus plantarum (L. plantarum) KY1032 on the fasting plasma metabolome.
A randomized, double-blind, placebo-controlled study was conducted on 92 participants with hypertriglyceridemia but without diabetes. Over a 12-week testing period, the probiotic group consumed 2 g of powder containing 5 × 10(9) colony-forming units (cfu) of L. curvatus HY7601 and 5 × 10(9) cfu of L. plantarum KY1032 each day, whereas the placebo group consumed the same product without probiotics. Fasting plasma metabolomes were profiled using UPLC-LTQ-Orbitrap MS. After 12 weeks of treatment, the probiotic group displayed a 20% reduction (p = 0.001) in serum TGs and 25% increases (p=0.001) in apolipoprotein A-V (apoA-V). At the 12-week follow-up assessment, the following 11 plasma metabolites were significantly reduced in the probiotic group than the placebo group: palmitoleamide, palmitic amide, oleamide, and lysophosphatidyl choline (lysoPC) containing C14:0, C16:1, C16:0, C17:0, C18:3, C18:2, C18:1, and C20:3. In the probiotic group, changes (▵) in TG were negatively correlated with ▵ apoA-V, which was positively correlated with ▵ FFA. In addition, ▵ FFA was strongly and positively correlated with ▵ lysoPCs in the probiotic group but not the placebo group.
The triglyceride-lowering effects of probiotic supplementation, partly through elevated apoA-V, in borderline to moderate hypertriglyceridemic subjects showed reductions in plasma metabolites, fatty acid primary amides and lysoPCs (NCT02215694; http://www.clinicaltrials.gov). Clinical trials: NCT02215694; http://www.clinicaltrials.gov.
本研究评估了食用弯曲乳杆菌(L. curvatus)HY7601和植物乳杆菌(L. plantarum)KY1032这两种益生菌菌株对空腹血浆代谢组的降甘油三酯(TG)作用。
对92名患有高甘油三酯血症但无糖尿病的参与者进行了一项随机、双盲、安慰剂对照研究。在为期12周的测试期内,益生菌组每天食用2克含有5×10⁹菌落形成单位(cfu)的弯曲乳杆菌HY7601和5×10⁹ cfu的植物乳杆菌KY1032的粉末,而安慰剂组食用不含益生菌的相同产品。使用超高效液相色谱-线性离子阱-轨道阱质谱(UPLC-LTQ-Orbitrap MS)对空腹血浆代谢组进行分析。治疗12周后,益生菌组血清TG降低了20%(p = 0.001),载脂蛋白A-V(apoA-V)增加了25%(p = 0.001)。在12周的随访评估中,益生菌组有11种血浆代谢物比安慰剂组显著降低,包括棕榈油酸酰胺、棕榈酰胺、油酸酰胺以及含有C14:0、C16:1、C16:0、C17:0、C18:3、C18:2、C18:1和C20:3的溶血磷脂酰胆碱(lysoPC)。在益生菌组中,TG的变化(▵)与▵ apoA-V呈负相关,而▵ apoA-V与▵游离脂肪酸(FFA)呈正相关。此外,在益生菌组中,▵ FFA与▵ lysoPCs呈强正相关,而在安慰剂组中则无此相关性。
在临界至中度高甘油三酯血症受试者中,补充益生菌的降甘油三酯作用部分通过升高apoA-V实现,同时血浆代谢物、脂肪酸一级酰胺和lysoPCs减少(NCT02215694;http://www.clinicaltrials.gov)。临床试验:NCT02215694;http://www.clinicaltrials.gov。